Barbieri Raffaella, Alloisio Susanna, Ferroni Stefano, Nobile Mario
Institute of Biophysics, CNR, Via De Marini, 6 - 16149 Genoa, Italy.
Neurochem Int. 2008 Dec;53(6-8):255-62. doi: 10.1016/j.neuint.2008.05.001. Epub 2008 Sep 19.
Accumulating evidence indicates that astroglial syncytium plays key role in normal and pathological brain functions. Astrocytes both in vitro and in situ respond to extracellular adenine-based nucleotides via the activation of P2 receptors. Massive release of ATP from neurons and glial cells occurs as a result of pathological conditions of the brain leading to neuroinflammation and involving P2X7 receptors. In this study, we investigated whether P2X7 stimulation on cultured cortical astrocytes promoted a differential activation of mitogen-activated protein kinases (MAPKs), and whether the second messenger arachidonic acid (AA), which is also a key modulator of neuroinflammation, affected the P2X7-mediated MAPK phosphorylation. The results show that the synthetic P2X7 receptor agonist 2',3'-O-(4-benzoyl)benzoyl-ATP (BzATP), induced a concentration-dependent phosphorylation of MAPK ERK1/2, JNK and p38. Stimulation of ERK1/2, JNK and p38 phosphorylation was also obtained by pathophysiological levels of extracellularly applied AA. Interestingly, a robust potentiation of ERK1/2 phosphorylation was elicited by co-application of BzATP and AA, whereas no differences were observed in JNK or p38 phosphosignals. The kinases activation showed a differential dependence on the presence of extracellular Ca(2+). The potentiation of BzATP-mediated ERK1/2 phosphorylation was also observed in human embryonic kidney cells (HEK293) stably transfected with rat P2X7, but not in HEK cells expressing truncated P2X7 receptor lacking the full cytoplasmic carboxy-terminal or in those carrying the structurally related rat P2X2. AA and BzATP synergism in ERK1/2 activation was abolished by cyclo-oxygenase and lipoxygenase pathway inhibitors. The result that ERK1/2-mediated transduction pathway is synergistically modulated by ATP and AA signalling depicts possible novel pharmacological targets for interfering with pathological activation of astroglial cells.
越来越多的证据表明,星形胶质细胞合体在正常和病理脑功能中起关键作用。体外和原位的星形胶质细胞通过P2受体的激活对细胞外腺嘌呤核苷酸作出反应。由于脑部病理状况导致神经炎症并涉及P2X7受体,神经元和胶质细胞会大量释放ATP。在本研究中,我们调查了对培养的皮质星形胶质细胞进行P2X7刺激是否会促进丝裂原活化蛋白激酶(MAPK)的差异性激活,以及同样作为神经炎症关键调节因子的第二信使花生四烯酸(AA)是否会影响P2X7介导的MAPK磷酸化。结果显示,合成的P2X7受体激动剂2',3'-O-(4-苯甲酰基)苯甲酰基-ATP(BzATP)诱导了MAPK ERK1/2、JNK和p38的浓度依赖性磷酸化。细胞外施加的AA的病理生理水平也能刺激ERK1/2、JNK和p38的磷酸化。有趣的是,同时应用BzATP和AA会引发ERK1/2磷酸化的强烈增强,而在JNK或p38磷酸信号中未观察到差异。激酶激活对细胞外Ca(2+)的存在表现出不同的依赖性。在稳定转染大鼠P2X7的人胚肾细胞(HEK293)中也观察到了BzATP介导的ERK1/2磷酸化增强,但在表达缺乏完整胞质羧基末端的截短型P2X7受体的HEK细胞中或携带结构相关的大鼠P2X2的细胞中未观察到。环氧化酶和脂氧合酶途径抑制剂消除了AA和BzATP在ERK1/2激活中的协同作用。ERK1/2介导的转导途径受到ATP和AA信号协同调节的结果描绘了干扰星形胶质细胞病理激活的可能新的药理学靶点。